capecitabine tablets is a prescription medicine used to treat people with: \u2022 cancer of the colon that has spread to lymph nodes in the area close to the colon (Dukes\u2019 C stage), after they have surgery. \u2022 cancer of the colon or rectum (colorectal) that has spread to other parts of the body (metastatic). \u2022 breast cancer that has spread to other parts of the body (metastatic) together with another medicine called docetaxel after treatment with certain other anti cancer medicines have not worked. \u2022 breast cancer that has spread to other parts of the body and has not improved after treatment with paclitaxel and certain other anti-cancer medicines, or who cannot receive any more treatment with certain anti-cancer medicines. It is not known if XELODA is safe and effective in children.<\/p>\n
Active ingredient: capecitabine Inactive ingredients: anhydrous lactose, croscarmellose sodium, hydroxypropyl methylcellulose, microcrystalline cellulose, magnesium stearate and purified water. The peach or light peach film coating contains hydroxypropyl methylcellulose, talc, titanium dioxide, and synthetic yellow and red iron oxides. This Patient Information has been approved by the U.S. Food and Drug<\/p>\n
XELIRI ( Capecitabine (Xeloda) & Irinotecan Hydrochloride) is used to treat:<\/strong><\/p>\n This combination may also be used with other drugs or treatments or to treat other types of cancer.<\/p>\n If capecitabine tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: \u2022 Adjuv ant Colon Cancer \u2013Patients with Dukes\u2019 C colon cancer \u2022 Metastatic Colorectal Cancer \u2013First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred \u2022 Metastatic Breast Cancer \u2013In combination with docetaxel after failure of prior anthracyclinecontaining therapy \u2013As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen<\/p>\n Approval Date: 1998 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import capecitabine tablets\u201d based on the information you provide.<\/p>\n\n
How can 1 go about obtaining capecitabine tablets?<\/h3>\n
XELODA (capecitabine) tablets, for oral use Initial U.S. Approval: 1998<\/h5>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\nReferences<\/h3>\n
\n
\nSee Drugs@FDA for information about all of CDER\u2019s approved drugs and biological products.<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"Capecitabine tablets
\nfor oral use Initial U.S. Approval: 1998<\/h2>\nFacts about capecitabine tablets<\/h4>\n
\nProprietary Name: On Request
\nActive Ingredient(s): capecitabine tablets
\nDosage Forms And Strengths: Tablets: 150 mg and 500 mgTablets: 150 mg and 500 mg
\nCompany: Genentech
\nCurrent indications: <\/strong>Breast cancer, Colorectal cancer, Pancreatic adenocarcinoma, Stomach (gastric) cancer, esophageal cancer, or gastroesophageal junction cancer in adults, Stomach (gastric) cancer or gastroesophageal junction cancer in adults.
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here<\/a><\/p>\nAccess the best support services globally<\/h4>\n